title: Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity.
authors.forename: Koen
authors.initials: K
authors.lastname: van Besien
authors.forename: Viviane
authors.initials: V
authors.lastname: Schouten
authors.forename: Sandeep
authors.initials: S
authors.lastname: Parsad
authors.forename: Sonali
authors.initials: S
authors.lastname: Smith
authors.forename: Olatoyosi
authors.initials: O
authors.lastname: Odenike
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Artz
mesh_terms: D000368:Aged; D017809:Fatal Outcome; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000209:etiology; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy*; D016019:Survival Analysis; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus